WallStreetZenWallStreetZen

NYSE: ANRO
Alto Neuroscience Inc Stock Ownership - Who owns Alto Neuroscience?

Insider buying vs selling

Have Alto Neuroscience Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nicholas Conrad SmithCHIEF FINANCIAL OFFICER2024-03-284,550$16.56
$75.35kBuy
Nicholas Conrad SmithCHIEF FINANCIAL OFFICER2024-03-281,600$15.80
$25.28kBuy
Alpha Wave Global LP10% Owner2024-02-06600,000$16.00
$9.60MBuy
Amit EtkinPRESIDENT AND CEO2024-02-063,125$16.00
$50.00kBuy
Adam SavitzCHIEF MEDICAL OFFICER2024-02-0617,000$16.00
$272.00kBuy
Nicholas Conrad SmithCHIEF FINANCIAL OFFICER2024-02-061,563$16.00
$25.01kBuy

1 of 1

ANRO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANRO insiders and whales buy or sell their stock.

ANRO Shareholders

What type of owners hold Alto Neuroscience Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Alpha Wave Global LP13.79%3,707,757$52.58MInsider
Amit Etkin4.61%1,240,176$17.59MInsider
Apeiron Investment Group Ltd3.45%926,539$13.14MInsider
Christopher Nixon Cox2.66%715,653$10.15MInsider
Po Yu Jeff Chen0.18%47,709$676.51kInsider
Nicholas Conrad Smith0.10%26,866$380.96kInsider
Adam Savitz0.09%24,851$352.39kInsider
Gwill York0.09%23,917$339.14kInsider

1 of 1

ANRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANRO0.00%24.97%Net BuyingNet Buying
CBUS14.04%85.96%Net Buying
MREO11.20%4.59%
NGNE36.48%63.52%Net Buying
ADPT62.07%37.93%Net SellingNet Selling

Alto Neuroscience Stock Ownership FAQ

Who owns Alto Neuroscience?

Alto Neuroscience (NYSE: ANRO) is owned by 0.00% institutional shareholders, 24.97% Alto Neuroscience insiders, and 75.03% retail investors. Alpha Wave Global LP is the largest individual Alto Neuroscience shareholder, owning 3.71M shares representing 13.79% of the company. Alpha Wave Global LP's Alto Neuroscience shares are currently valued at $52.58M.

If you're new to stock investing, here's how to buy Alto Neuroscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.